Cadila gets stakeholders nod for scheme of arrangement with Zydus
New Delhi : Drug firm Cadila Healthcare has received overwhelming approval from stakeholders for scheme of arrangement between the company and Zydus Healthcare Ltd.
Almost 100 per cent shareholders have approved "the scheme of arrangement between Cadila Healthcare Ltd and Zydus Healthcare Ltd and their respective shareholders and creditors," Cadila Healthcare said in a BSE filing.
The voting results were the outcome of a National Company Law Tribunal (NCLT) convened meeting of the shareholders of the company held on March 30, 2017, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd